top of page

Pfizer Moves Into Cancer Treatment.


Well, well, well, my dear readers, what do we have here? Pfizer, one of the big pharma giants, has just completed a whopping $43 billion acquisition of Seagen, a relatively small cancer drug company that rakes in about $2 billion annually. Now, call me cheeky, but there's something fishy about this deal, and I'm not afraid to say it. Let's take a deep dive into the sinister aspects of this bizarre acquisition, shall we?


First things first, Pfizer, do you really need the cash? Apparently not, because they're planning to issue a staggering $31 billion in debt to fund this acquisition. Now, I'm not a financial expert, but something doesn't add up here. Why would they overpay by $43 billion for a company that barely makes $2 billion a year? It's like buying a mansion when you already have a castle.


But here's where it gets really interesting, folks. Pfizer, the same company that brought us the COVID-19 mRNA vaccines, is now entering the world of cancer treatment. Now, I'm not saying it's a bad thing, but there's a peculiar connection here. You see, some folks believe that Pfizer's mRNA vaccines may be causing what they call "Turbo Cancers." Yes, you heard me right, Turbo Cancers.


Based on extensive research and numerous articles, it appears that vaccinated individuals may be at risk of developing certain cancers at an alarming rate. We're talking about lymphoma, brain cancers, breast cancer, colon cancer, and lung cancer, to name a few. It's like a sinister bingo card of the worst cancers you can imagine.


Now, why on earth would Pfizer be interested in acquiring a cancer drug company, you ask? Well, it turns out that this acquisition takes them from being able to treat just 2 out of these 10 Turbo Cancers to a whopping 7 out of 10. Not bad, right? But hold your horses; there's more to this story.


Pfizer's CEO, Albert Bourla, has been doing the media rounds, talking about this colossal $43 billion cancer drug deal. And what he's saying is raising some eyebrows. He's claiming that 33% of people will get cancer, and entire families will be affected. He even likened the new cancer treatments to "missiles" that will target "most" cancers. And here's the kicker – he plans to produce them "AT SCALE," a phrase we've heard before with mRNA vaccines.

Now, I don't know about you, but when someone talks about producing something "AT SCALE," it raises a few questions in my cheeky little mind. Why the need for such a massive production scale? What are they not telling us? And why is Mr. Bourla so certain about the cancer epidemic that lies ahead?


Some financial analysts are scratching their heads over this deal, too. They theorize that it would take Pfizer at least a decade just to break even from this acquisition. So, financially, it makes absolutely no sense for them. Unless... unless there's something more to this story that we're not being told.


So, my dear readers, as we unravel this enigmatic acquisition, I leave you with one question: What's really going on behind the scenes at Pfizer, and why are they venturing into the world of cancer treatment "AT SCALE"? It's a mystery that only time will reveal, but mark my words, there's more to this story than meets the eye. Stay cheeky, my friends, and always question the narrative.


Thats Just what I think though, in the meantime:


Trust No Single Source

Trust Your Gut &

Stay Curious


Sally Joe


For media inquiries, please contact:


UK - 020 3404 2295

USA - 0650 278 4440

AUS - 02 9072 9499


Help Support Sally Joe and the rest of our Authors by visiting the store to get your copy of the latest Anonymous Author Novel, or some cool merch.


Comments


bottom of page